AlphaOne Investment Services LLC increased its holdings in AtriCure Inc. (NASDAQ:ATRC) by 34.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 229,725 shares of the medical device company’s stock after purchasing an additional 59,200 shares during the quarter. AlphaOne Investment Services LLC’s holdings in AtriCure were worth $4,190,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of ATRC. Teacher Retirement System of Texas bought a new stake in shares of AtriCure in the fourth quarter worth $203,000. Campbell & CO Investment Adviser LLC bought a new stake in shares of AtriCure in the third quarter worth $205,000. Capital Fund Management S.A. grew its stake in shares of AtriCure by 57.3% in the fourth quarter. Capital Fund Management S.A. now owns 15,100 shares of the medical device company’s stock worth $275,000 after purchasing an additional 5,500 shares during the last quarter. UBS Asset Management Americas Inc. bought a new stake in shares of AtriCure in the second quarter worth $315,000. Finally, Voya Investment Management LLC grew its stake in shares of AtriCure by 7.9% in the second quarter. Voya Investment Management LLC now owns 17,158 shares of the medical device company’s stock worth $416,000 after purchasing an additional 1,250 shares during the last quarter. 89.49% of the stock is currently owned by institutional investors.
In other news, CFO M. Andrew Wade sold 2,000 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $18.41, for a total transaction of $36,820.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Justin J. Noznesky sold 4,000 shares of the company’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $17.03, for a total transaction of $68,120.00. The disclosure for this sale can be found here. 11.90% of the stock is currently owned by corporate insiders.
AtriCure Inc. (NASDAQ:ATRC) opened at $18.00 on Monday. AtriCure Inc. has a fifty-two week low of $14.88 and a fifty-two week high of $25.18. The company has a current ratio of 2.28, a quick ratio of 1.65 and a debt-to-equity ratio of 0.20.
COPYRIGHT VIOLATION WARNING: This report was originally published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/3222719/alphaone-investment-services-llc-has-4-19-million-position-in-atricure-inc-atrc.html.
AtriCure, Inc is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures.
Want to see what other hedge funds are holding ATRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AtriCure Inc. (NASDAQ:ATRC).
Receive News & Ratings for AtriCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AtriCure and related companies with MarketBeat.com's FREE daily email newsletter.